Efalizumab and weight decreased Patient Reports February 11, 2012

Efalizumab Side Effects Report #4617905-9
Efalizumab side effect was reported by a Consumer or non-health professional from on Mar 11, 2005. Male patient, 67 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium increased, dehydration, nausea , vertigo, weight decreased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4648456-3
Efalizumab side effect was reported by a Health Professional from on Apr 20, 2005. Male patient, 67 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium increased, dehydration, influenza, nausea , vertigo, weight decreased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with INSULIN, FUROSEMIDE, ASPIRIN. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4691088-1
Efalizumab side effect was reported by a Physician from on May 27, 2005. Male patient, 57 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, fatigue, helicobacter gastritis, malaise, oesophageal candidiasis, vomiting, weight decreased. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient recovered.

Efalizumab Side Effects Report #4628065-2
Efalizumab side effect was reported by a Health Professional from on Mar 23, 2005. Male patient, 43 years of age, was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, pancreatitis, weight decreased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with RAMIPRIL, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #4650486-2
Efalizumab side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 43 years of age, was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alcohol poisoning, blood creatinine increased, intestinal obstruction, pancreatitis, weight decreased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with RAMIPRIL, AMLODIPINE BESYLATE, HYDROXYZINE, CANDESARTAN. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #6094634-9
Efalizumab side effect was reported by a Physician from SWITZERLAND on Feb 20, 2009. Male patient, weighting 143.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, bladder cancer , malaise, polyarthritis, pyrexia, vitamin b12 deficiency, weight decreased. Efalizumab dosage: 0.7 MG/KG, SINGLE. During the same period patient was treated with DURAGESIC, PANTOZOL, OXPRENOLOL, IRBESARTAN, LORAZEPAM, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4644942-0
Efalizumab side effect was reported by a Health Professional from on Apr 13, 2005. Male patient, 43 years of age, was diagnosed with hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: abdominal distension, blood creatinine increased, inflammation, intestinal obstruction, pancreatitis, weight decreased. Efalizumab dosage: 1 MG/KG, 1 WEEK, SUBCUTANEOUS. During the same period patient was treated with RAMIPRIL, AMLODIPINE BESYLATE, HYDROXYZINE, CANDESARTAN. Patient was hospitalized. Patient recovered.